Co-founder of ACYTE
BSc (Sydney), PhD (UNSW), FTSE, FAICD
Peter Gray is Director of the Australian Institute for Bioengineering and Nanotechnology, Professor of Bioengineering at the University of Queensland, and Emeritus Professor of Biotechnology at the University of NSW. He has had commercial experience in the USA working for Eli Lilly and Co and Cetus Corporation and has held academic positions at University of College London and at the University of California, Berkeley. He has built up R&D capabilities in mammalian cell culture to be the leading group in Australia, with an extensive collaborative network of international research groups and corporations. Prof Gray serves on a number of Boards and is involved in a wide range of international biotechnology activities. He has served as a member of the Pharmaceutical Sub-Committee of the Therapeutic Goods Administration (TGA) Australia and is one of the founders and a past President of the Australian Biotechnology Association, AusBiotech. Prof Gray is regularly involved as an expert witness in biotechnology patent cases and has extensive consulting experience.
B.Bus, CA, MAICD – Company Secretary
Stephen has extensive experience in mergers and acquisitions, business valuations, accountancy services, and income tax compliance gained from positions as Company Secretary and Chief Financial Officer of various public companies and with major chartered accountancy firms in Australia and the United Kingdom. He provides company secretarial services for a number of start-up technology and ASX listed and unlisted public companies.
Stephen has a Bachelor of Business in Accountancy, Graduate Diploma in Applied Corporate Governance and is a member of the Institute of Chartered Accountants in Australia and the Australian Institute of Company Directors.
Dr Alfredo Martinez-Coll Alfredo graduated with a B.Sc. in Biomedical Engineering (minor in artificial organ design) in 1986 from Louisiana Tech University (USA). He has more than 16 years experience in biomedical research in Venezuela, the United States and Australia covering design of artificial organs, cardiovascular and cerebrovascular physiology, membrane transport and oxygen transport to tissue.
In 1995 Alfredo moved to Australia and joined the Cooperative Research Centre for Cardiac Technology (CRC-CT); obtaining his Doctorate from the University of Technology, Sydney in 1999 and completing his post-doctoral training with the Faculty of Engineering in 2003.
Alfredo has worked in the area of intellectual property and commercialisation of technology across a number of Area Health Services and academia for the last 7 years. In 2006 he joined NewSouth Innovations Pty Ltd- NSi (the commercialisation company of UNSW) where he is currently Senior Business Development Manager looking after the life sciences and medicine. In 2008 and 2010 he was involved in significant equity transactions for investments into two NSi spin-off companies. Alfredo has been a member for the NSW Branch of the AusMedtech since 2008. His main areas of interest are sustainable funding for science, entrepreneurship, innovation, project management in science and business development -all part of a number of submissions to the State and Commonwealth governments.